Popular Diabetes Medications May Protect Against Alzheimer’s Disease, UF Researchers Find
UF researchers have found that a pair of popular glucose-lowering medications may have protective effects against the development of Alzheimer’s disease and related dementias in patients with Type 2 diabetes.
New Funding Secured To Support Clinical GMP Manufacturing Expansion at Rise Therapeutics
UF Startup Rise Therapeutics announced that it has received funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institute of Health (NIH).
